• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体γ调节剂预测器(PGMP_v1):用于改善2型糖尿病管理的化学空间探索与计算洞察

PPARγ modulator predictor (PGMP_v1): chemical space exploration and computational insights for enhanced type 2 diabetes mellitus management.

作者信息

Amin Sk Abdul, Sessa Lucia, Gayen Shovanlal, Piotto Stefano

机构信息

Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy.

Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, 700032, India.

出版信息

Mol Divers. 2025 Feb 1. doi: 10.1007/s11030-025-11118-5.

DOI:10.1007/s11030-025-11118-5
PMID:39891837
Abstract

Peroxisome proliferator-activated receptor gamma (PPARγ) plays a critical role in adipocyte differentiation and enhances insulin sensitivity. In contemporary drug discovery, in silico design strategies offer significant advantages by revealing essential structural insights for lead optimization. The study is guided by two main objectives: (i) a ligand-based approach to explore the chemical space of PPARγ modulators followed by molecular docking ensembles (MDEs) to investigate ligand-binding interactions, (ii) the development of a supervised ML model for a large dataset of compounds targeting PPARγ. Additionally, the combination of chemical space networks with ML models enables the rapid screening and prediction of PPARγ modulators. These modeling analyses will assist medicinal chemists in designing more potent PPARγ modulators. To further enhance accessibility for the scientific community, we developed an online tool, "PGMP_v1," aimed at prospective screening for PPARγ modulators. The tool "PGMP_v1" is available at the provided link https://github.com/Amincheminfom/PGMP_v1 . The integration of these computational methods has uncovered crucial structural motifs that are essential for PPARγ activity, advancing the development of more effective modulators in the future.

摘要

过氧化物酶体增殖物激活受体γ(PPARγ)在脂肪细胞分化中起关键作用,并增强胰岛素敏感性。在当代药物发现中,计算机辅助设计策略通过揭示用于先导优化的基本结构见解而具有显著优势。该研究由两个主要目标指导:(i)基于配体的方法探索PPARγ调节剂的化学空间,随后进行分子对接集合(MDE)以研究配体-结合相互作用,(ii)为靶向PPARγ的大量化合物数据集开发监督式机器学习模型。此外,化学空间网络与机器学习模型的结合能够快速筛选和预测PPARγ调节剂。这些建模分析将有助于药物化学家设计更有效的PPARγ调节剂。为了进一步提高科学界的可及性,我们开发了一个在线工具“PGMP_v1”,旨在对PPARγ调节剂进行前瞻性筛选。工具“PGMP_v1”可通过提供的链接https://github.com/Amincheminfom/PGMP_v1获得。这些计算方法的整合揭示了对PPARγ活性至关重要的关键结构基序,推动了未来更有效调节剂的开发。

相似文献

1
PPARγ modulator predictor (PGMP_v1): chemical space exploration and computational insights for enhanced type 2 diabetes mellitus management.过氧化物酶体增殖物激活受体γ调节剂预测器(PGMP_v1):用于改善2型糖尿病管理的化学空间探索与计算洞察
Mol Divers. 2025 Feb 1. doi: 10.1007/s11030-025-11118-5.
2
In silico analysis of polyphenols modulate bovine PPARγ to increase milk fat synthesis in dairy cattle via the MAPK signaling pathways.多酚通过 MAPK 信号通路调节奶牛 PPARγ 增加奶牛乳脂合成的计算机分析。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae248.
3
Exploring Type II Diabetes Inhibitors from Genus Daphne Plant-species: An Integrated Computational Study.探索瑞香属植物物种中的II型糖尿病抑制剂:一项综合计算研究。
Comb Chem High Throughput Screen. 2025;28(8):1413-1442. doi: 10.2174/0113862073262227231005074024.
4
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.过氧化物酶体增殖物激活受体γ激动剂用于预防中风或短暂性脑缺血发作患者的复发性中风和其他血管事件。
Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD010693. doi: 10.1002/14651858.CD010693.pub4.
5
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
6
In vivo and in silico insights into the antidiabetic efficacy of EVOO and hydroxytyrosol in a rat model.对特级初榨橄榄油和羟基酪醇在大鼠模型中抗糖尿病功效的体内和计算机模拟研究
J Nutr Biochem. 2025 Jan;135:109775. doi: 10.1016/j.jnutbio.2024.109775. Epub 2024 Oct 5.
7
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.过氧化物酶体增殖物激活受体 γ 激动剂预防卒中和短暂性脑缺血发作患者复发卒中和其他血管事件。
Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD010693. doi: 10.1002/14651858.CD010693.pub6.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
Molecular interactions between piperine and peroxisome proliferator-activated receptor gamma ligand-binding domain revealed using co-crystallization studies.利用共结晶研究揭示胡椒碱与过氧化物酶体增殖物激活受体γ配体结合域之间的分子相互作用。
Acta Crystallogr F Struct Biol Commun. 2025 May 1;81(Pt 5):201-206. doi: 10.1107/S2053230X25002377. Epub 2025 Apr 2.

引用本文的文献

1
First 4D-QSAR Study of Human Kynurenine 3 Monooxygenase (hKMO) Inhibitors: Integrating Chemical Space Networks and an Explainable Artificial Intelligence Platform for Neurodegenerative Disease Drug Discovery.人类犬尿氨酸3单加氧酶(hKMO)抑制剂的首次4D-QSAR研究:整合化学空间网络和可解释人工智能平台用于神经退行性疾病药物发现。
ACS Omega. 2025 Aug 29;10(35):39751-39762. doi: 10.1021/acsomega.5c03404. eCollection 2025 Sep 9.

本文引用的文献

1
Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione's in fructose induced insulin resistant rats.新型噻唑烷二酮类药物通过果糖诱导的胰岛素抵抗大鼠逆转胰岛素抵抗以治疗 2 型糖尿病。
Eur J Med Chem. 2024 Dec 15;280:116939. doi: 10.1016/j.ejmech.2024.116939. Epub 2024 Oct 5.
2
Discovery of Palindrome Dual PPARγ-GPR40 Agonists for Treating Type 2 Diabetes.用于治疗2型糖尿病的回文双PPARγ-GPR40激动剂的发现
ChemMedChem. 2024 Dec 16;19(24):e202400492. doi: 10.1002/cmdc.202400492. Epub 2024 Nov 4.
3
Exploring fingerprints for antidiabetic therapeutics related to peroxisome proliferator-activated receptor gamma (PPARγ) modulators: A chemometric modeling approach.
探索与过氧化物酶体增殖物激活受体 γ(PPARγ)调节剂相关的抗糖尿病治疗的指纹图谱:一种化学计量建模方法。
Comput Biol Chem. 2024 Oct;112:108142. doi: 10.1016/j.compbiolchem.2024.108142. Epub 2024 Jul 2.
4
Classification of Healthy Family Indicators in Indonesia Based on a K-means Cluster Analysis.基于 K-均值聚类分析的印度尼西亚健康家庭指标分类。
J Prev Med Public Health. 2024 May;57(3):234-241. doi: 10.3961/jpmph.23.497. Epub 2024 May 5.
5
Discovery of New Dual-Target Agents Against PPAR-γ and α-Glucosidase Enzymes with Molecular Modeling Methods: Molecular Docking, Molecular Dynamic Simulations, and MM/PBSA Analysis.采用分子对接、分子动力学模拟和 MM/PBSA 分析等方法发现新型双重靶向 PPAR-γ 和α-葡萄糖苷酶的药物。
Protein J. 2024 Jun;43(3):577-591. doi: 10.1007/s10930-024-10196-y. Epub 2024 Apr 20.
6
PPAR agonists as add-on treatment with metformin in management of type 2 diabetes: a systematic review and meta-analysis.PPAR 激动剂联合二甲双胍治疗 2 型糖尿病的系统评价和荟萃分析。
Sci Rep. 2024 Apr 16;14(1):8809. doi: 10.1038/s41598-024-59390-z.
7
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.2023 年的 ChEMBL 数据库:一个涵盖多种生物活性数据类型和时间段的药物发现平台。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1180-D1192. doi: 10.1093/nar/gkad1004.
8
YASARA Model-Interactive Molecular Modeling from Two Dimensions to Virtual Realities.雅莎拉模型——从二维到虚拟现实的交互式分子建模。
J Chem Inf Model. 2023 Oct 23;63(20):6177-6182. doi: 10.1021/acs.jcim.3c01136. Epub 2023 Oct 2.
9
Tree-Based Machine Learning Models with Optuna in Predicting Impedance Values for Circuit Analysis.基于树的机器学习模型与Optuna用于预测电路分析的阻抗值。
Micromachines (Basel). 2023 Jan 20;14(2):265. doi: 10.3390/mi14020265.
10
Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist.受结构生物学启发,开发了一系列人过氧化物酶体增殖物激活受体γ(PPARγ)配体:从激动剂到拮抗剂。
Int J Mol Sci. 2023 Feb 15;24(4):3940. doi: 10.3390/ijms24043940.